Standard Diagnostics and PATH collaborate to
Contact: Amy MacIver, 206.302.4522, [email protected] Seattle and Seoul, October 18, 2012–PATH and Standard Diagnostics, Inc., (SD) announce their intent to enter into a commercialization agreement whereby SD will manufacture and distribute a novel Ov16 rapid test for the neglected tropical disease onchocerciasis, …
Get Price